Daily non-political popular news in brief.
Analysis confirms benefits of combining trastuzumab and chemotherapy
07-07-2007 · EurekAlert!A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
Read more »
Keywords: analysis, confirms, benefits, combining, trastuzumab, chemotherapy, analysi, confirm, benefit
« Previous | Next »
Similar news on "Analysis confirms benefits of combining trastuzumab and chemotherapy":
- Benefits of trastuzumab are lasting, reducing both HER2 + breast cancer deaths and recurrence
06-04-2007 · EurekAlert!
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Similar news · Read more »
- Chromium picolinate shows greater benefits in diabetes care than other forms of chromium
01-31-2007 · EurekAlert!
Nutrition 21, Inc. (NASDAQ: NXXI) reported today that a peer reviewed analysis on chromium picolinate was published in the current edition of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. The review, which analyzed research on chromium picolinate, supports the consistent beneficial effects of chromium picolinate and refutes a previous review that analyzed efficacy after combining results from all types of supplemental chromium.
Similar news · Read more »
- MIT ethanol analysis confirms benefits of biofuels
01-08-2007 · Massachusetts Institute of Technology (MIT)
A new MIT analysis shows that the amount of energy used by converting corn into ethanol and the amount of fossil energy of the ethanol produced are so close that several factors can easily change whether ethanol ends up a net energy winner or loser.
Similar news · Read more »
- Tip sheet Annals of Internal Medicine, June 19, 2007
06-18-2007 · EurekAlert!
In this issue: 1. Women with Diabetes left behind in overall drop in death rates in the US, 2. Substance in soy products increased bone density compared to placebo, 3. Meta-analysis showed that acupuncture has no meaningful short-term benefits in pain or function compared to Sham control trials, 4. Different ways to describe the benefits of treatments influence patients' willingness to accept the treatments, and 5. Two views on stopping randomized trials early because of apparent benefit.
Similar news · Read more »
- A search for protection against chemotherapy cardiotoxicity
12-20-2007 · EurekAlert!
The use of several chemotherapeutic agents in oncology is limited by their cardiac toxicity. Recent experimental studies suggest that recombinant human erythropoietin (rhEPO) can be considered as a protective agent against cardiac ischemic injury. Here we show that pretreatment by rhEPO protects myocardium against cardiotoxicity induced by acute doxorubicin or trastuzumab exposure, using the isolated rat heart model. Further clinical investigations are now needed to explore the potential benefit of rhEPO in oncology.
Similar news · Read more »
- Research shows survival benefit for leukemia patients treated with arsenic trioxide
06-04-2007 · EurekAlert!
Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
Similar news · Read more »
- High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer
12-13-2007 · EurekAlert!
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
- MGH researchers confirm that bone marrow restores fertility in female mice
07-31-2007 · EurekAlert!
A new study from Massachusetts General Hospital researchers confirms that female mice that receive bone marrow transplantation after fertility-destroying chemotherapy can go on to have successful pregnancies throughout their normal reproductive life. The report verifies that donor marrow can restore fertility in mice through an as-yet unidentified mechanism. While donor-derived oocytes were observed in the ovaries of marrow recipients, all pups born were from the recipients' own eggs.
Similar news · Read more »
- Study confirms limited human-to-human spread of avian-flu virus in Indonesia in 2006
08-28-2007 · EurekAlert!
In the first systematic, statistical analysis of its kind, infectious disease modeling experts at Fred Hutchinson Cancer Research Center confirm that the avian influenza A (H5N1) virus in 2006 spread between a small number of people within a family in Indonesia.
Similar news · Read more »
- Study confirms health benefits of whole grains
05-09-2007 · EurekAlert!
A diet high in whole grain foods is associated with a significantly lower risk of developing cardiovascular disease, including heart disease and stroke, according to an analysis conducted by researchers at Wake Forest University School of Medicine.
Similar news · Read more »
